12-111418767-G-C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_005475.3(SH2B3):​c.622G>C​(p.Glu208Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000663 in 1,478,578 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00076 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00065 ( 3 hom. )

Consequence

SH2B3
NM_005475.3 missense

Scores

1
9
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:7B:3

Conservation

PhyloP100: 6.24

Publications

30 publications found
Variant links:
Genes affected
SH2B3 (HGNC:29605): (SH2B adaptor protein 3) This gene encodes a member of the SH2B adaptor family of proteins, which are involved in a range of signaling activities by growth factor and cytokine receptors. The encoded protein is a key negative regulator of cytokine signaling and plays a critical role in hematopoiesis. Mutations in this gene have been associated with susceptibility to celiac disease type 13 and susceptibility to insulin-dependent diabetes mellitus. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2014]
SH2B3 Gene-Disease associations (from GenCC):
  • acute lymphoblastic leukemia
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics
  • growth retardation-mild developmental delay-chronic hepatitis syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • primary familial polycythemia due to EPO receptor mutation
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)
  • schizophrenia
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)
  • thrombocythemia 1
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03058815).
BP6
Variant 12-111418767-G-C is Benign according to our data. Variant chr12-111418767-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 30445.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000763 (116/152086) while in subpopulation AMR AF = 0.00222 (34/15288). AF 95% confidence interval is 0.00164. There are 0 homozygotes in GnomAd4. There are 50 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 Unknown,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SH2B3NM_005475.3 linkc.622G>C p.Glu208Gln missense_variant Exon 2 of 8 ENST00000341259.7 NP_005466.1 Q9UQQ2Q59H48

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SH2B3ENST00000341259.7 linkc.622G>C p.Glu208Gln missense_variant Exon 2 of 8 1 NM_005475.3 ENSP00000345492.2 Q9UQQ2
SH2B3ENST00000550925.2 linkc.427G>C p.Glu143Gln missense_variant Exon 1 of 2 5 ENSP00000473529.1 R4GN84

Frequencies

GnomAD3 genomes
AF:
0.000763
AC:
116
AN:
151976
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00223
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.0000944
Gnomad MID
AF:
0.0350
Gnomad NFE
AF:
0.000721
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00109
AC:
84
AN:
77392
AF XY:
0.00101
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00233
Gnomad ASJ exome
AF:
0.00188
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000856
Gnomad OTH exome
AF:
0.00396
GnomAD4 exome
AF:
0.000652
AC:
865
AN:
1326492
Hom.:
3
Cov.:
32
AF XY:
0.000674
AC XY:
441
AN XY:
654560
show subpopulations
African (AFR)
AF:
0.000268
AC:
7
AN:
26158
American (AMR)
AF:
0.00234
AC:
63
AN:
26954
Ashkenazi Jewish (ASJ)
AF:
0.00184
AC:
42
AN:
22860
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29372
South Asian (SAS)
AF:
0.000380
AC:
28
AN:
73758
European-Finnish (FIN)
AF:
0.0000298
AC:
1
AN:
33534
Middle Eastern (MID)
AF:
0.0166
AC:
65
AN:
3922
European-Non Finnish (NFE)
AF:
0.000546
AC:
576
AN:
1055104
Other (OTH)
AF:
0.00151
AC:
83
AN:
54830
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
45
90
135
180
225
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000763
AC:
116
AN:
152086
Hom.:
0
Cov.:
32
AF XY:
0.000672
AC XY:
50
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.000120
AC:
5
AN:
41520
American (AMR)
AF:
0.00222
AC:
34
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5150
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4816
European-Finnish (FIN)
AF:
0.0000944
AC:
1
AN:
10596
Middle Eastern (MID)
AF:
0.0377
AC:
11
AN:
292
European-Non Finnish (NFE)
AF:
0.000721
AC:
49
AN:
67936
Other (OTH)
AF:
0.00331
AC:
7
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00116
Hom.:
0
Bravo
AF:
0.000892
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000741
AC:
4
ExAC
AF:
0.000383
AC:
25

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:7Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:6
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 05, 2021
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Thrombocythemia 1 Pathogenic:1Benign:1
Aug 12, 2010
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

May 10, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hepatoblastoma Uncertain:1
-
Molecular Oncology - Human Genetics Lab, University of Sao Paulo
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:research

- -

Primary myelofibrosis Benign:1
Aug 27, 2021
Genetics and Molecular Pathology, SA Pathology
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BS1-supp, PP3 -

Hereditary cancer Benign:1
Sep 11, 2024
Mendelics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following: it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease, and/or has normal protein function, and/or has lack of segregation with disease, and/or has been detected in co-occurrence with known pathogenic variant, and/or has lack of disease association in case-control studies, and/or is located in a region inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.31
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.50
CADD
Uncertain
26
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.45
T
Eigen
Uncertain
0.59
Eigen_PC
Uncertain
0.53
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.81
T
M_CAP
Uncertain
0.16
D
MetaRNN
Benign
0.031
T
MetaSVM
Benign
-0.71
T
MutationAssessor
Uncertain
2.2
M
PhyloP100
6.2
PrimateAI
Pathogenic
0.90
D
PROVEAN
Benign
-1.2
N
REVEL
Benign
0.11
Sift
Uncertain
0.022
D
Sift4G
Uncertain
0.039
D
Polyphen
1.0
D
Vest4
0.29
MVP
0.86
MPC
1.5
ClinPred
0.078
T
GERP RS
3.9
PromoterAI
0.040
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.25
gMVP
0.40
Mutation Taster
=23/77
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs202080221; hg19: chr12-111856571; COSMIC: COSV57983848; API